Meghan Martin
About
In The Last Decade
Meghan Martin
10 papers receiving 422 citations
Peers
Comparison fields: 5 of 50
- Radiology, Nuclear Medicine and Imaging 380
- Oncology 107
- Pathology and Forensic Medicine 79
- Molecular Biology 73
- Organic Chemistry 45
Countries citing papers authored by Meghan Martin
This map shows the geographic impact of Meghan Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meghan Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meghan Martin more than expected).
Fields of papers citing papers by Meghan Martin
This network shows the impact of papers produced by Meghan Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meghan Martin. The network helps show where Meghan Martin may publish in the future.
Co-authorship network of co-authors of Meghan Martin
This figure shows the co-authorship network connecting the top 25 collaborators of Meghan Martin. A scholar is included among the top collaborators of Meghan Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meghan Martin. Meghan Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 12 | |
| 4 | 9 | |
| 5 | Pretargeted radioimmunotherapy of human colorectal xenografts with bispecific antibody and 131I-labeled bivalent hapten. | 63 |
| 6 | Delivery of therapeutic doses of radioiodine using bispecific antibody-targeted bivalent haptens. | 37 |
| 7 | Bispecific monoclonal antibody-mediated targeting of an indium-111-labeled DTPA dimer to primary colorectal tumors: pharmacokinetics, biodistribution, scintigraphy and immune response. | 68 |
| 8 | 19 | |
| 9 | Targeting of indium 111-labeled bivalent hapten to human melanoma mediated by bispecific monoclonal antibody conjugates: imaging of tumors hosted in nude mice. | 93 |
| 10 | In vitro and in vivo targeting of radiolabeled monovalent and divalent haptens with dual specificity monoclonal antibody conjugates: enhanced divalent hapten affinity for cell-bound antibody conjugate. | 124 |
| 11 | 30 | |
| 12 | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.